0

TAK-779

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP229005805
CAS229005-80-5
Structure
Molecular Weight531.13
Description≥98% (HPLC)
SolubilityH2O: 3 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice

Eva J A van Wanrooij, Hester Happé, Arnaud D Hauer, Paula de Vos, Takeshi Imanishi, Hiromi Fujiwara, Theo J C van Berkel, Johan Kuiper

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2642-7.

PMID: 16239591

1

Synthesis of Thiophene-Based TAK-779 Analogues by C-H Arylation

Anna Junker, Junichiro Yamaguchi, Kenichiro Itami, Bernhard Wünsch

J Org Chem. 2013 Jun 7;78(11):5579-86.

PMID: 23642160

1

TAK-779 (Takeda)

J A Esté

Curr Opin Investig Drugs. 2001 Mar;2(3):354-6.

PMID: 11575704

1

TAK-779, a Nonpeptide CC Chemokine Receptor Antagonist, Protects the Brain Against Focal Cerebral Ischemia in Mice

Shinya Takami, Masabumi Minami, Takahiro Katayama, Izumi Nagata, Shobu Namura, Masamichi Satoh

J Cereb Blood Flow Metab. 2002 Jul;22(7):780-4.

PMID: 12142563

1

The Chemokine Receptor Antagonist, TAK-779, Decreased Experimental Autoimmune Encephalomyelitis by Reducing Inflammatory Cell Migration Into the Central Nervous System, Without Affecting T Cell Function

Jia Ni, Yi-Na Zhu, Xiang-Gen Zhong, Yu Ding, Li-Fei Hou, Xian-Kun Tong, Wei Tang, Shiro Ono, Yi-Fu Yang, Jian-Ping Zuo

Br J Pharmacol. 2009 Dec;158(8):2046-56.

PMID: 20050195

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode